Metraipolis › archive › dc_f33358eedd27
Dose-Escalated Upadacitinib for Refractory Myositis in Anti-Jo-1-Positive Antisynthetase Syndrome: A Case Report — Europe PMC PMID:42756780
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42756780
- DOI
- 10.1155/crrh/5972090
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T07:47:56.293Z
- SHA-256 of the archived text
f3022fdd50be190f4035ca9042e38a408cafedf952c30fb4495e641e5aa45135- Stable URL of this page
https://metraipolis.com/documento/dc_f33358eedd27
How to cite
Dose-Escalated Upadacitinib for Refractory Myositis in Anti-Jo-1-Positive Antisynthetase Syndrome: A Case Report — Europe PMC PMID:42756780 — Europe PMC (en), https://europepmc.org/article/MED/42756780 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f33358eedd27 (Metraipolis archive dc_f33358eedd27, sha256 f3022fdd50be190f4035ca9042e38a408cafedf952c30fb4495e641e5aa45135)
BibTeX
@misc{dcf33358eedd27,
title = {Dose-Escalated Upadacitinib for Refractory Myositis in Anti-Jo-1-Positive Antisynthetase Syndrome: A Case Report — Europe PMC PMID:42756780},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42756780},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f33358eedd27; sha256 f3022fdd50be190f4035ca9042e38a408cafedf952c30fb4495e641e5aa45135},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42756780. Agents can read the archived copy with the MCP tool read_document.